SCHEMBL6617841

SCHEMBL6617841

C[C@H](O)C(Oc1ccc2sc(-c3ccccc3)nc2c1)N1CCN(CCn2cc(-c3ccccc3)cn2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.39
CYP2C9 P11712 3/20 0.39
CYP1A2 P05177 2/20 0.39
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
NFKB1 P19838 3/20 0.38
NFKB2 Q00653 3/20 0.38
RELA Q04206 3/20 0.38
HPGD P15428 3/20 0.38
PKM P14618 2/20 0.38
LIPC P11150 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
KDM4E B2RXH2 2/20 0.37
S1PR1 P21453 1/20 0.36
PLK1 P53350 2/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6259851 1.00 CYP3A4 (0.39) CYP3A4CYP2C9CYP1A2NPC1RAB9A
SCHEMBL6615762 0.95 CYP3A4 (0.38) CYP3A4CYP2C9CYP1A2NPC1RAB9A
SCHEMBL6612602 0.92 CYP3A4 (0.48) CYP3A4CYP2C9CYP1A2
SCHEMBL6257661 0.92 CYP3A4 (0.48) CYP3A4CYP2C9CYP1A2
SCHEMBL6256460 0.89 CYP3A4 (0.38) CYP3A4CYP2C9CYP1A2LIPCS1PR1
SCHEMBL6256837 0.87 MAPT (0.37) CYP3A4CYP2C9CYP1A2SMN1; SMN2LIPC
SCHEMBL6613291 0.84 CYP1A2 (0.42) CYP3A4CYP2C9CYP1A2LIPC
SCHEMBL6258490 0.84 CYP1A2 (0.42) CYP3A4CYP2C9CYP1A2LIPC
SCHEMBL5965111 0.84 CYP3A4 (0.53) CYP3A4CYP2C9CYP1A2PKMKDM4E
SCHEMBL5901541 0.84 CYP3A4 (0.53) CYP3A4CYP2C9CYP1A2PKMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1406898-A1 SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2004-04-14 EP disclosed
WO-2003008411-A1 SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2003-01-30 WO disclosed